Grifols Investor

Grifols is a global healthcare company.
Technology: COVID, Cell_Therapies
Industry: Longevity
Headquarters: Barcelona, Catalonia, Spain
Founded Date: 1940-01-01
Employees Number: 10001+
Funding Status: IPO
Investor Type: N/A
Investment Stage: N/A
Number Of Exits: 4
Estimated Revenue: $1B to $10B

Visit Website
https://twitter.com/grifols_press
Register and Claim Ownership